Assessing the Efficacy of RADPAD Protection Drape in Reducing Radiation Exposure to Operators in the Cardiac Catheterization Laboratory: A Systematic Review and Meta-Analysis

• Published in: Curēus (Palo Alto, CA) CA), 2024-04, Vol.16 (4), p.e59215-e59215
• Main Authors: Bahar, Abdul Rasheed, Khanal, Resha, Hamza, Mohammad, Goru, Rohit K, Shafiq, Aimen, Haider, Mobeen Z, Basit, Salman Abdul, Bahar, Yasemin, Umer, Ahmed Muaaz, Sattar, Yasar, Alraies, M Chadi
• Format: Article
• Language: English
• Subjects: Angioplasty; Cancer; Cardiac catheterization; Cardiology; Clinical trials; Dosimetry; Intubation; Laboratories; Meta-analysis; Other; Patients; Radiation; Radiology; Systematic review
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.59215

One of the leading environmental hazards, ionizing radiation, is linked to several detrimental health consequences in the body. RADPAD (Worldwide Innovations & Technologies, Inc., Kansas City, Kansas) is a sterile, lead-free, lightweight, disposable radiation protection shield. We conducted a systematic review and meta-analysis to determine the effectiveness of RADPAD protection drapes in the cardiac catheterization lab and how they can aid interventional cardiologists in becoming subjected to less scatter radiation. PubMed, Embase, and Google Scholar were searched for studies discussing the efficacy of RADPAD protection drapes in reducing radiation exposure to operators in the cardiac catheterization laboratory. A random-effects model was used to pool odds ratios (ORs) and 95% confidence intervals (CIs) for endpoints: primary operator exposure dose, dose area product (DAP), relative exposure, and screening time. Our analysis included 892 patients from six studies. Compared to the No-RADPAD group, primary operator exposure dose (E) was significantly lower in the RADPAD group (OR: -0.9, 95% CI: -1.36 to -0.43, I = 80.5%, p = 0.0001). DAP was comparable between both groups (OR: 0.008, 95% CI: -0.12 to -0.14, I = 0%, p = 0.9066). There was no difference in the relative exposure (E/DAP) (OR: -0.47, 95% CI: -0.96 to 0.02, I = 0%, p = 0.90) and screening time (OR: 0.13, 95% CI: 0.08 to 0.35, I = 0%, p = 0.22) between the two groups. The interventional cardiology laboratory is exposed to significantly less scatter radiation during procedures owing to the RADPAD protective drape. Consequently, all catheterization laboratories could be advised to employ RADPAD protective drapes.